相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clonal Expansion of Stem/Progenitor Cells in Cancer, Fibrotic Diseases, and Atherosclerosis, and CD47 Protection of Pathogenic Cells
R. Majeti et al.
ANNUAL REVIEW OF MEDICINE (2022)
Overlooking the obvious? On the potential of treatment alterations to predict patient-specific therapy response
Ingo Roeder et al.
EXPERIMENTAL HEMATOLOGY (2021)
Improving cancer treatments via dynamical biophysical models
M. Kuznetsov et al.
PHYSICS OF LIFE REVIEWS (2021)
Multistage feedback-driven compartmental dynamics of hematopoiesis
Nathaniel Vincent Mon Pere et al.
ISCIENCE (2021)
Mathematical modelling of the hematopoietic stem cell-niche system: Clonal dominance based on stem cell fitness
Rasmus Kristoffer Pedersen et al.
JOURNAL OF THEORETICAL BIOLOGY (2021)
Understanding Normal and Pathological Hematopoietic Stem Cell Biology Using Mathematical Modelling
Mia Brunetti et al.
CURRENT STEM CELL REPORTS (2021)
A Quantitative Paradigm for Decision-Making in Precision Oncology
Dalit Engelhardt et al.
TRENDS IN CANCER (2021)
Optimal experimental design for mathematical models of haematopoiesis
Luis Martinez Lomeli et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2021)
Strategies for calibrating models of biology
Mark N. Read et al.
BRIEFINGS IN BIOINFORMATICS (2020)
Integration of mathematical model predictions into routine workflows to support clinical decision making in haematology
Katja Hoffmann et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2020)
Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML
Tom Haehnel et al.
CANCER RESEARCH (2020)
Mathematical Modeling Provides Evidence for Niche Competition in Human AML and Serves as a Tool to Improve Risk Stratification
Thomas Stiehl et al.
CANCER RESEARCH (2020)
Designing combination therapies using multiple optimal controls
Jesse A. Sharp et al.
JOURNAL OF THEORETICAL BIOLOGY (2020)
Unraveling Hematopoiesis through the Lens of Genomics
L. Alexander Liggett et al.
CELL (2020)
High-risk additional chromosomal abnormalities at low blast counts herald death by CML (vol 34, pg 2074, 2020)
Rudiger Hehlmann et al.
LEUKEMIA (2020)
In-silico comparison of two induction regimens (7+3 vs 7+3 plus additional bone marrow evaluation) in acute myeloid leukemia treatment
Jan Christoph Banck et al.
BMC SYSTEMS BIOLOGY (2019)
A computational model of feedback-mediated hematopoietic stem cell differentiation in vitro
Bhushan Mahadik et al.
PLOS ONE (2019)
Clonal hematopoiesis of indeterminate potential and its impact on patient trajectories after stem cell transplantation
Derek S. Park et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia With Losing Major Molecular Response as a Definition for Molecular Relapse: A Systematic Review and Meta-Analysis
Kang-kang Chen et al.
FRONTIERS IN ONCOLOGY (2019)
BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors
Maria Stella Pennisi et al.
FRONTIERS IN ONCOLOGY (2019)
Feedback regulation in a stem cell model with acute myeloid leukaemia
Jianfeng Jiao et al.
BMC SYSTEMS BIOLOGY (2018)
Mathematical modeling of the impact of cytokine response of acute myeloid leukemia cells on patient prognosis
Thomas Stiehl et al.
SCIENTIFIC REPORTS (2018)
Quantitative prediction of long-term molecular response in TKI-treated CML - Lessons from an imatinib versus dasatinib comparison
Ingmar Glauche et al.
SCIENTIFIC REPORTS (2018)
The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers
Rhonda J. Staversky et al.
SCIENTIFIC REPORTS (2018)
Clinical consequences of clonal hematopoiesis of indeterminate potential
David P. Steensma
BLOOD ADVANCES (2018)
Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy
TaeHyung Kim et al.
BLOOD (2017)
Measurement of BCR-ABL1 transcripts on the International Scale in the United States: current status and best practices
Ranjana Arora et al.
LEUKEMIA & LYMPHOMA (2017)
Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia
Gabriel Etienne et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Ascorbate regulates haematopoietic stem cell function and leukaemogenesis
Michalis Agathocleous et al.
NATURE (2017)
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
Andreas Hochhaus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy
Clemens Woywod et al.
PLOS ONE (2017)
Regulation of Hematopoiesis and Hematological Disease by TGF-β Family Signaling Molecules
Kazuhito Naka et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression
Luisa Cimmino et al.
CELL (2017)
ASXL1 and BIM germ line variants predict response and identify CML patients with the greatest risk of imatinib failure
Justine E. Marum et al.
BLOOD ADVANCES (2017)
The chronic myeloid leukemia stem cell: stemming the tide of persistence
Tessa L. Holyoake et al.
BLOOD (2017)
MIP-1α/CCL3-expressing basophil-lineage cells drive the leukemic hematopoiesis of chronic myeloid leukemia in mice
Tomohisa Baba et al.
BLOOD (2016)
Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib Therapy
Noortje Thielen et al.
CLINICAL CANCER RESEARCH (2016)
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial
Jorge E. Cortes et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Feedback mechanisms control coexistence in a stem cell model of acute myeloid leukaemia
Helena L. Crowell et al.
JOURNAL OF THEORETICAL BIOLOGY (2016)
Blood Cell Dynamics: Half of a Century of Modelling
L. Pujo-Menjouet
MATHEMATICAL MODELLING OF NATURAL PHENOMENA (2016)
Rapid Discrimination Among Putative Mechanistic Models of Biochemical Systems
Jason G. Lomnitz et al.
SCIENTIFIC REPORTS (2016)
CML Patients with Primary Resistance or Suboptimal Response to TKI Therapy Have Variants in Genes Affecting Drug Absorption and Metabolism
Paavo Pietarinen et al.
BLOOD (2016)
Natural course and biology of CML
Bradley Chereda et al.
ANNALS OF HEMATOLOGY (2015)
Cell lineage branching as a strategy for proliferative control
Gentian Buzi et al.
BMC BIOLOGY (2015)
Treatment of Chronic Myelogenous Leukemia by Blocking Cytokine Alterations Found in Normal Stem and Progenitor Cells
Robert S. Welner et al.
CANCER CELL (2015)
Cell Division Patterns in Acute Myeloid Leukemia Stem-like Cells Determine Clinical Course: A Model to Predict Patient Survival
Thomas Stiehl et al.
CANCER RESEARCH (2015)
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets
David T. Yeung et al.
BLOOD (2015)
Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline
Susan Branford et al.
BLOOD (2014)
Conversion of Danger Signals into Cytokine Signals by Hematopoietic Stem and Progenitor Cells for Regulation of Stress-Induced Hematopoiesis
Jimmy L. Zhao et al.
CELL STEM CELL (2014)
Clonal selection and therapy resistance in acute leukaemias: mathematical modelling explains different proliferation patterns at diagnosis and relapse
Thomas Stiehl et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2014)
Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib
B. Hanfstein et al.
LEUKEMIA (2014)
Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells
Meng Zhao et al.
NATURE MEDICINE (2014)
The ecology in the hematopoietic stem cell niche determines the clinical outcome in chronic myeloid leukemia
Adam L. MacLean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Feedback Signals in Myelodysplastic Syndromes: Increased Self-Renewal of the Malignant Clone Suppresses Normal Hematopoiesis
Thomas Walenda et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
Merging concepts - coupling an agent-based model of hematopoietic stem cells with an ODE model of granulopoiesis
Axel Krinner et al.
BMC SYSTEMS BIOLOGY (2013)
Phenotypic deconstruction of gene circuitry
Jason G. Lomnitz et al.
CHAOS (2013)
Critical Differences in Hematopoiesis and Lymphoid Development between Humans and Mice
Chintan Parekh et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
MIP-1α/CCL3-mediated maintenance of leukemia-initiating cells in the initiation process of chronic myeloid leukemia
Tomohisa Baba et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Dynamical modelling of haematopoiesis: an integrated view over the system in homeostasis and under perturbation
Erica Manesso et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2013)
Differential regulation of myeloid leukemias by the bone marrow microenvironment
Daniela S. Krause et al.
NATURE MEDICINE (2013)
Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib
David Marin et al.
BLOOD (2012)
Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia
Bin Zhang et al.
CANCER CELL (2012)
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
B. Hanfstein et al.
LEUKEMIA (2012)
Chronic Myeloid Leukemia: Clinical Impact of BCR-ABL1 Mutations and Other Lesions Associated With Disease Progression
Thomas Ernst et al.
SEMINARS IN ONCOLOGY (2012)
Hematopoiesis
Michael A. Rieger et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Early Switch to Nilotinib Does Not Overcome the Adverse Outcome for CML Patients Failing to Achieve Early Molecular Response On Imatinib, Despite Excellent Overall Outcomes in the TIDEL II Trial
David T. Yeung et al.
BLOOD (2012)
Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells
Min Tang et al.
BLOOD (2011)
IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development
Damien Reynaud et al.
CANCER CELL (2011)
A Multicellular Basis for the Origination of Blast Crisis in Chronic Myeloid Leukemia
Rainer K. Sachs et al.
CANCER RESEARCH (2011)
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
Amie S. Corbin et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib
Carlo Gambacorti-Passerini et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Automated construction and analysis of the design space for biochemical systems
Rick A. Fasani et al.
BIOINFORMATICS (2010)
Hematopoiesis and its disorders: a systems biology approach
Zakary L. Whichard et al.
BLOOD (2010)
BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells
Mirle Schemionek et al.
BLOOD (2010)
TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia
Kazuhito Naka et al.
NATURE (2010)
Molecular biology of bcr-abl1-positive chronic myeloid leukemia
Alfonso Quintas-Cardama et al.
BLOOD (2009)
Stem-cell driven cancer Hands-off regulation of cancer development
Carolina Vicente-Duenas et al.
CELL CYCLE (2009)
Predictors of Primary Imatinib Resistance in Chronic Myelogenous Leukemia Are Distinct From Those in Secondary Imatinib Resistance
Wenyong W. Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
IFNα activates dormant haematopoietic stem cells in vivo
Marieke A. G. Essers et al.
NATURE (2009)
Phenotypes and tolerances in the design space of biochemical systems
Michael A. Savageau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Modeling of Asymmetric Cell Division in Hematopoietic Stem Cells-Regulation of Self-Renewal Is Essential for Efficient Repopulation
Anna Marciniak-Czochra et al.
STEM CELLS AND DEVELOPMENT (2009)
Cell Lineages and the Logic of Proliferative Control
Arthur D. Lander et al.
PLOS BIOLOGY (2009)
Eradication of Chronic Myeloid Leukemia Stem Cells: A Novel Mathematical Model Predicts No Therapeutic Benefit of Adding G-CSF to Imatinib
Jasmine Foo et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Mathematical modeling of genesis and treatment of chronic myeloid leukemia
Matthias Horn et al.
CELLS TISSUES ORGANS (2008)
Retinoic acid signaling in myelopoiesis
Karen Drumea et al.
CURRENT OPINION IN HEMATOLOGY (2008)
Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
Akihiro Abe et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: Implications for the outcome of Imatinib treatment and discontinuation
Dominik Wodarz
MEDICAL HYPOTHESES (2008)
Effect of Cellular Quiescence on the Success of Targeted CML Therapy
Natalia L. Komarova et al.
PLOS ONE (2007)
Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase
E. Diaz-Blanco et al.
LEUKEMIA (2007)
Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications
Ingo Roeder et al.
NATURE MEDICINE (2006)
Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylate
HG Jorgensen et al.
CLINICAL CANCER RESEARCH (2006)
A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake
LR Devireddy et al.
CELL (2005)
Dynamics of chronic myeloid leukaemia
F Michor et al.
NATURE (2005)
Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis
S Koschmieder et al.
BLOOD (2005)
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
CHM Jamieson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors
BJP Huntly et al.
CANCER CELL (2004)
A computational model of human granulopoiesis to simulate the hematotoxic effects of multicycle polychemotherapy
C Engel et al.
BLOOD (2004)
Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro
SM Graham et al.
BLOOD (2002)
Physiological migration of hematopoietic stem and progenitor Celts
DE Wright et al.
SCIENCE (2001)
分享论文
